Best practices and considerations for outsourcing with CDMOs

Cell & Gene Therapy Insights 2024; 10(3), 291–295

DOI: 10.18609/cgti.2024.043

Published: 11 April
Viewpoint
Joseph W Graskemper



“...the question of how companies should approach CDMO selection is more important than ever.”